BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19761616)

  • 21. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N; Kloos B; Cassella M; Podgrabinska S; Persaud K; Wu Y; Pytowski B; Skobe M
    Cancer Res; 2006 Mar; 66(5):2650-7. PubMed ID: 16510584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance.
    Price-Schiavi SA; Jepson S; Li P; Arango M; Rudland PS; Yee L; Carraway KL
    Int J Cancer; 2002 Jun; 99(6):783-91. PubMed ID: 12115478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer.
    van Agthoven T; Timmermans M; Dorssers LC; Henzen-Logmans SC
    Int J Cancer; 1995 Dec; 63(6):790-3. PubMed ID: 8847135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
    Singh AP; Moniaux N; Chauhan SC; Meza JL; Batra SK
    Cancer Res; 2004 Jan; 64(2):622-30. PubMed ID: 14744777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases.
    Valla M; Mjønes PG; Engstrøm MJ; Ytterhus B; Bordin DL; van Loon B; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
    J Histochem Cytochem; 2018 Nov; 66(11):787-799. PubMed ID: 30052477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    Falck AK; Fernö M; Bendahl PO; Rydén L
    World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of MUC4 in human milk and at the luminal surfaces of blood vessels.
    Zhang J; Perez A; Yasin M; Soto P; Rong M; Theodoropoulos G; Carothers Carraway CA; Carraway KL
    J Cell Physiol; 2005 Jul; 204(1):166-77. PubMed ID: 15672420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
    Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
    Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
    Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
    Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells.
    Komatsu M; Yee L; Carraway KL
    Cancer Res; 1999 May; 59(9):2229-36. PubMed ID: 10232613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of angiogenesis in lymph node metastases with outcome of breast cancer.
    Guidi AJ; Berry DA; Broadwater G; Perloff M; Norton L; Barcos MP; Hayes DF
    J Natl Cancer Inst; 2000 Mar; 92(6):486-92. PubMed ID: 10716967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.
    Kim WG; Lee J
    Int J Surg Pathol; 2017 Aug; 25(5):397-405. PubMed ID: 28145149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
    Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma.
    Nam KH; Noh TW; Chung SH; Lee SH; Lee MK; Hong SW; Chung WY; Lee EJ; Park CS
    Thyroid; 2011 Jul; 21(7):745-50. PubMed ID: 21615302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells.
    Li Y; Wu C; Chen T; Zhang J; Liu G; Pu Y; Zhu J; Shen C; Zhang Y; Zeng N; Zhang X
    Oncol Rep; 2016 Dec; 36(6):3449-3455. PubMed ID: 27748843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node.
    Turner RR; Chu KU; Qi K; Botnick LE; Hansen NM; Glass EC; Giuliano AE
    Cancer; 2000 Aug; 89(3):574-81. PubMed ID: 10931456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
    Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.